期刊文献+

Saitohin基因Q7R多态性与肌萎缩侧索硬化的相关性研究 被引量:1

Association between Q7R polymorphism of saitohin gene and amyotrophic lateral sclerosis
下载PDF
导出
摘要 目的探讨中国人种Saitohin基因(STH)Q7R多态性与肌萎缩侧索硬化(amyotrophic lateral sclerosis,ALS)的发病相关性。方法采用病例对照研究,应用递减聚合酶链式反应限制性酶切片段长度多态性(Touchdown-PCR-RFLP)方法检测135例ALS患者和135例正常人STH基因Q7R多态性。结果所有DNA样本的STH基因均为QQ型纯合子。结论STH基因Q7R多态性与ALS无相关性。 Objective To evaluate the association between the Q7R polymorphism of saitohin gene(STH) and amyotrophic lateral sclerosis. Methods The Q7R polymorphism was examined in 270 subjects (ALS: 135; controls: 135) from China,by the Touchdown polymerase chain reaction restriction fragment length polyrnorphism(Touchdown PCR -RFLP). Results Only QQ homozygote was found in the all subjects. Conclusion The results indicated that the Q7R polymorphism of STH gene was not associated with ALS.
出处 《临床荟萃》 CAS 2010年第4期292-294,共3页 Clinical Focus
关键词 肌萎缩侧索硬化 基因 聚合酶链反应 amyotrophic lateral sclerosis gene polymerase chain reaction
  • 相关文献

参考文献12

  • 1de Vos KJ, Grierson AJ, Ackerley S, et al. Role of axonal transport in neurodegenerative diseases [J]. Annu Rev Neurosci, 2008,31: 151-173.
  • 2张明明,何美霞,华海婴.tau蛋白和退行性神经病变[J].中国老年学杂志,2009,29(2):251-253. 被引量:5
  • 3Sussmuth SD, Tumani H, Ecker D, et al. Amyotrophic lateral sclerosis:disease stage related changes of tau protein and S100 beta in cerebrospinal fluid and creatine kinase in serum[J]. Neurosci Lett,2003,353(1) :57-60.
  • 4Strong MJ, Yang W, Strong WL, et al. Tau protein hyperphosphorylation in sporadic ALS with cognitive impairment[J]. Neurology, 2006,66 (11 ) : 1770-1771.
  • 5Paladino P,Valentino F,Piccoli T,et al. Cerebrospinal fluid tau protein is not a biological marker in amyotrophic lateral sclerosis[J]. Eur J Neurol,2009,16(2) :257-261.
  • 6Conrad C, Vianna C, Freeman M, et al. A polymorphie gene nested within an intron of the tau gene: implications for Alzheimer' s disease[J]. Proc Natl Acad Sci USA, 2002, 99 (11) :7751-7756.
  • 7Glatz DC,Rujescu D, Tang Y,et al. The alternative splicing of tau exon 10 and it s regulatory proteins CLK2 and TRA2- BETA1 changes in sporadic Alzheimer's disease [J]. J Neurochem, 2006,96 (3) : 635-644.
  • 8Levecque C, Elbaz A, Clavel J, et al. Association of polymorphisms in the Tau and Saitohin genes with Parkinson's disease[J]. J Neurol Neurosurg Psychiatry, 2004,75 (3) : 478- 480.
  • 9Jankovic N, Kecmanovic M, Dimitrijevic R, et al. HD phenocopies-possible role of Saitohin gene[J]. Int J Neurosci, 2008,118(3):391-397.
  • 10de Silva R, Hope A,Pittman A,et al. Strong association of the Saitohin gene Q7 variant with progressive supranuclear palsy [J]. Neurology, 2003,61 (3) : 407-409.

二级参考文献19

  • 1Sergeant N, Bretteville A, Hamdane M, et al. Biochemistry of tau in Alzheimer's disease and related neurological disorders [ J ]. Expert Rev Proteomics,2008 ; 5 (2) :207 -24.
  • 2Boeve BF, Hutton M. Refining frontotemporal dementia with parkinsonism linked to chromosome 17 :introducing FTDP-17 (MAPT) and FTDP-17 ( PGRN ) [ J ]. Arch Neurol,2008 ;65 (4) :460-4.
  • 3Jellinger KA. Neuropathological aspects of Alzheimer disease, Parkinson disease and frontotemporal dementia [ J ]. Neurodegener Dis, 2008 ; 5 ( 3- 4) :118-21.
  • 4Ballatore C, Lee VM, Trojanowski JQ. tau-mediated neurodegeneration in Alzheimer's disease and related disorders[ J ]. Nat Rev Neurosci ,2007;8 (9) :663-72.
  • 5Perez M, Santa-Maria I ,Tortosa E, et al. The role of the VQIVYK peptide in tau protein phosphorylation [ J ]. J Neurochem, 2007 ; 103 ( 4 ) : 1447- 60.
  • 6Liu Y, Liu F, Iqbal K, et al. Decreased glucose transporters correlate to abnormal hyperphosphorylation of tau in Alzheimer disease [ J ]. FEBS Lett,2008 ;582(2) :359-64.
  • 7Deng Y, Li B, Liu F,et al. Regulation between O-GlcNA cylation and phospborylation of neurofilament-M and their dysregulation in Alzheimer disease[ J]. FASEB J,2008 ;22 ( 1 ) :138-45.
  • 8Terwel D, Lasrado R, Snauwaert J,et al. Changed conformation of mutant tau-P301L underlies the moribund tauopathy, absent in progressive, nonlethal axonopathy of tau-4R/2N transgenic mice[J]. J Biol Chem,2005 ;280(5 ) :3963-73.
  • 9Maeda S, Sahara N, Saito Y, et al. Granular tau oligomers as intermediates of tau filaments [ J ]. Biochemistry,2007 ;46 ( 12 ) :3856-61.
  • 10de la Torte JC. Pathophysiology of neuronal enemy crisis in Alzheimer's disease[J]. Neurodegener Dis,2008 ;5 ( 34 ) : 126-32.

共引文献4

同被引文献11

  • 1胡俊,史树贵,李露斯.神经系统疾病与超氧化物歧化酶[J].中国临床康复,2005,9(33):130-132. 被引量:8
  • 2Turner MR, Bowser R, Bruijn L, et al. Mechanisms, models and biomarkers in amyotrophic lateral sclerosis [J]. Amyotroph Lateral Scler Frontotemporal Degener, 2013, 14 ( Suppl 1 ) : 19- 32.
  • 3Redler RL, Dokholyan NV. The complex molecular biology of amyotrophic lateral sclerosis (ALS)[J]. Prog Mol Biol Transl Sci,2012,107:215- 262.
  • 4Cozzolino M, Pesaresi MG, Gerbino V, et al. Amyotrophic lateral sclerosis: new insights into underlying molecular mechanisms and opportunities for therapeutic intervention[J]. Antioxid Redox Signal,2012,17(9) :1277-1330.
  • 5Zheng Z, Guo X, Wei Q, et al. Serum uric acid level is associated with the prevalence but not with survival of amyotrophic lateral sclerosis in a Chinese population[J]. Metab Brain Dis,2014 Mar 1. [Epub ahead of print].
  • 6Bolognin S, Cozzi B, Zambenedetti P, et al. Metallothioneins and the central nervous system: from a deregulation in neurodegenerative diseases to the development of new therapeutic approaches[J]. J Alzheimers Dis. 2014 Feb 27. [Epub ahead of print].
  • 7Brasil AA,Belati A, Mannarino SC, et al. The involvement of GSH in the activation of human Sodl linked to FALS in chronologically aged yeast cells[J]. FEMS Yeast Res, 2013,13 (5) :433-440.
  • 8潘静,陈生弟.氧化应激与神经退行性疾病[J].国际神经病学神经外科学杂志,2008,35(2):143-145. 被引量:18
  • 9李一梅,刘宽芝.氧化应激、线粒体功能障碍与2型糖尿病[J].临床荟萃,2014,29(2):213-216. 被引量:26
  • 10韩秀华,孙丽华,邹健,孟亚红,范小红,王雪莲.还原型谷胱甘肽对多发性骨髓瘤患者沙利度胺相关的周围神经病变的保护作用[J].临床荟萃,2014,29(4):410-413. 被引量:5

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部